Richard Bartram - Chief Financial Officer at Esperion Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
ESPR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Richard Bartram since 10 Mar 2025

Holdings reported by Richard Bartram for Esperion Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 82,751 $103,025 $1.24 14 Mar 2022 Direct
Stock Option (right to buy 159,000 14 Mar 2022 Direct Common Stock 159,000

Transactions reported by Richard Bartram for Esperion Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.